On Aug 31, 2021 ARS Pharmaceuticals closed a Series D round and raised $55,000,000 from Deerfield Management, RA Capital Management, SR One, featuring lead investors […]
Series D – ARS Pharmaceuticals
On Aug 31, 2021 ARS Pharmaceuticals closed a Series D round and raised $55,000,000 from Deerfield Management, RA Capital Management, SR One, featuring lead investors […]
Series D – ARS Pharmaceuticals
On Aug 31, 2021 ARS Pharmaceuticals closed a Series D round and raised $55,000,000 from Deerfield Management, RA Capital Management, SR One, featuring lead investors […]
Series D – ARS Pharmaceuticals
On Aug 31, 2021 ARS Pharmaceuticals closed a Series D round and raised $55,000,000 from Deerfield Management, RA Capital Management, SR One, featuring lead investors […]
Series B – Cardior Pharmaceuticals
On Aug 25, 2021 Cardior Pharmaceuticals closed a Series B round and raised €64,000,000 from BioMedPartners, Bristol Myers Squibb, coparion, Fund+, Hadean Ventures, High-Tech Grunderfonds, […]
Series B – Cardior Pharmaceuticals
On Aug 25, 2021 Cardior Pharmaceuticals closed a Series B round and raised €64,000,000 from BioMedPartners, Bristol Myers Squibb, coparion, Fund+, Hadean Ventures, High-Tech Grunderfonds, […]
Series C – Molcure
On Aug 18, 2021 Molcure closed a Series C round and raised ¥800,000,000 from GMO VenturePartners, JAFCO Group, Japan Post Capital, Nippon Chemiphar, SBI Investment, […]
Series C – Molcure
On Aug 18, 2021 Molcure closed a Series C round and raised ¥800,000,000 from GMO VenturePartners, JAFCO Group, Japan Post Capital, Nippon Chemiphar, SBI Investment, […]
Seed Round – Mammogen
On Jun 30, 2021 Mammogen closed a Seed round and raised $2,000,000. The round was oversubscribed by a diverse group of high-net-worth investors, comprising 52% […]
Series A – ArriVent Biopharma
On Jun 30, 2021 ArriVent Biopharma closed a Series A round and raised $90,000,000 from Boyu Capital, Hillhouse Capital Group, Lilly Asia Ventures, Lyra Capital, […]
